Tuberculosis (TB)

WHO TB advisory bodies

Latent Tuberculosis Infection Task Force

The Latent Tuberculosis Infection Task Force aims to raise the profile of programmatic management of LTBI particularly in low incidence countries, including monitoring and evaluation of implemented activities, as well as promoting research.

HIV/TB Task Force

The HIV/TB Task Force advises WHO at all levels on intensifying the HIV/TB response in order to reduce new HIV-related TB infections, and eliminating HIV-associated TB deaths in high TB and HIV burden countries and concentrated HIV epidemic settings.

Strategic and Technical Advisory Group for TB (STAG-TB)

STAG-TB provides objective, ongoing technical and strategic advice to WHO related to TB care and control. STAG-TB’s objectives are to provide the Director-General, through the Stop TB Department, an independent evaluation of the strategic, scientific, and technical aspects of WHO’s TB activities, review progress and challenges in WHO’s TB-related core functions, review and make recommendations on committees and working groups, and make recommendations on WHO’s TB activity priorities.

WHO Global Task Force on TB Impact Measurement

The WHO Global Task Force on TB Impact Measurement was established in June 2006 and includes experts in TB epidemiology, representatives from major technical and financial partners, and representatives from countries with a high burden of TB.

Task Force for New Drug Policy Development

A Task Force for new drug policy development was established to advise and contribute to the development of a strategic plan to develop new policy recommendations for the treatment of TB taking into account recent advances in drug development, and prepare for optimal uptake of new TB drugs in programmatic conditions.

“Tuberculosis kills five thousand people every day. The social and economic impacts are devastating, including poverty, stigma and discrimination. While the world has committed to ending the TB epidemic by 2030, actions and investments don’t match the political rhetoric. We need a dynamic, global, multisectoral approach. The good news is that we finally have two great opportunities to move forward: the first WHO Global Ministerial Conference to End TB in Moscow in 2017, followed by the first UN General Assembly High-Level Meeting on TB in 2018. These will build momentum, get different sectors engaged, and accelerate our efforts to make TB history."

Dr Tedros Adhanom Ghebreyesus, WHO Director-General